This year, Critical Path Institute® (C-Path) proudly marks 20 years of advancing regulatory science and reshaping how new treatments are developed and delivered to individuals and families affected by Alzheimer’s disease, Parkinson’s, type 1 diabetes, rare and pediatric conditions, and more. To commemorate this milestone, BizTucson has published a special report titled “Critical Path Institute: Moving Drugs to Market, Smarter, Faster for 20 Years,” highlighting the organization’s global impact since its founding in 2005.
The in-depth issue includes a milestone timeline of C-Path’s achievements, powerful insights from founder Dr. Raymond Woosley, Board Chair Wainwright Fishburn, and Tammy McLeod of the Flinn Foundation, and highlights the organization’s progress in key areas such as neurology and rare disease.
A feature on CEO Klaus Romero and President & COO Kristen Swingle offers a behind-the-scenes look at the leadership duo steering C-Path into its next decade of innovation and growth. Additionally, the issue celebrates Swingle’s recent recognition as one of BizTucson’s 2025 Women Leading the Region—a well-deserved honor for her leadership and commitment to C-Path’s mission.
Read the full special issue here.
Read Kristen Swingle’s “Women Leading the Region” feature here.
We are proud to celebrate this 20-year milestone with our partners, collaborators, and community—and look forward to continuing our mission to improve global health for decades to come.
